Sarah A. Bannon

1.2k total citations
33 papers, 743 citations indexed

About

Sarah A. Bannon is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, Sarah A. Bannon has authored 33 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 15 papers in Hematology and 13 papers in Genetics. Recurrent topics in Sarah A. Bannon's work include Acute Myeloid Leukemia Research (15 papers), Genetic factors in colorectal cancer (13 papers) and Cancer Genomics and Diagnostics (8 papers). Sarah A. Bannon is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Genetic factors in colorectal cancer (13 papers) and Cancer Genomics and Diagnostics (8 papers). Sarah A. Bannon collaborates with scholars based in United States, Puerto Rico and Canada. Sarah A. Bannon's co-authors include Maureen E. Mork, Courtney D. DiNardo, Patrick M. Lynch, Eduardo Vilar, Miguel A. Rodrı́guez-Bigas, Y. Nancy You, Binwu Ying, Mark J. Routbort, Keyur P. Patel and Hagop M. Kantarjian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Sarah A. Bannon

31 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah A. Bannon United States 14 303 285 263 180 166 33 743
Chimene Kesserwan United States 14 82 0.3× 179 0.6× 153 0.6× 224 1.2× 240 1.4× 24 661
Lucia Casarino Italy 13 130 0.4× 131 0.5× 323 1.2× 87 0.5× 162 1.0× 26 608
Ilana Zalcberg Brazil 14 196 0.6× 231 0.8× 297 1.1× 44 0.2× 246 1.5× 53 739
Hadwiga Nowotny Austria 9 224 0.7× 131 0.5× 327 1.2× 48 0.3× 210 1.3× 12 701
Jorge A. Spinolo United States 11 109 0.4× 436 1.5× 379 1.4× 68 0.4× 150 0.9× 18 794
Maureen E. Mork United States 13 431 1.4× 380 1.3× 60 0.2× 148 0.8× 124 0.7× 35 725
Anna Aventı́n Spain 20 232 0.8× 152 0.5× 495 1.9× 69 0.4× 372 2.2× 58 938
Maitrayee Goswami United States 16 149 0.5× 165 0.6× 506 1.9× 43 0.2× 191 1.2× 31 735
Gianluigi Castoldi Italy 19 180 0.6× 252 0.9× 483 1.8× 60 0.3× 237 1.4× 36 957
Giuseppe Lentini Germany 10 178 0.6× 104 0.4× 109 0.4× 95 0.5× 124 0.7× 27 659

Countries citing papers authored by Sarah A. Bannon

Since Specialization
Citations

This map shows the geographic impact of Sarah A. Bannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Bannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Bannon more than expected).

Fields of papers citing papers by Sarah A. Bannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Bannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Bannon. The network helps show where Sarah A. Bannon may publish in the future.

Co-authorship network of co-authors of Sarah A. Bannon

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Bannon. A scholar is included among the top collaborators of Sarah A. Bannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Bannon. Sarah A. Bannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bannon, Sarah A., et al.. (2022). Assessing patient attitudes toward genetic testing for hereditary hematologic malignancy. European Journal Of Haematology. 110(1). 109–116.
2.
Lachowiez, Curtis A., Sarah A. Bannon, Sanam Loghavi, et al.. (2020). Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations. American Journal of Hematology. 95(11). E313–E315. 3 indexed citations
3.
DiNardo, Courtney D., Hannah C. Beird, Marcos R. Estecio, et al.. (2020). Germline DNMT3A mutation in familial acute myeloid leukaemia. Epigenetics. 16(5). 567–576. 7 indexed citations
4.
Quesada, Andres, Mark J. Routbort, Courtney D. DiNardo, et al.. (2019). DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease. American Journal of Hematology. 94(7). 757–766. 71 indexed citations
5.
Mork, Maureen E., Sarah A. Bannon, Patrick M. Lynch, et al.. (2019). Outcomes of disease-specific next-generation sequencing gene panel testing in adolescents and young adults with colorectal cancer. Cancer Genetics. 235-236. 77–83. 2 indexed citations
6.
Dalle, Iman Abou, Sarah A. Bannon, Keyur P. Patel, et al.. (2019). Germline Genetic Predisposition to Myeloid Neoplasia From GATA2 Gene Mutations: Lessons Learned From Two Cases. JCO Precision Oncology. 3(3). 1–5. 2 indexed citations
7.
Swaminathan, Mahesh, Sarah A. Bannon, Mark J. Routbort, et al.. (2019). Hematologic malignancies and Li–Fraumeni syndrome. Molecular Case Studies. 5(1). a003210–a003210. 50 indexed citations
8.
Bannon, Sarah A., Maria F. Montiel, Jennifer B. Goldstein, et al.. (2018). High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Cancer Prevention Research. 11(11). 679–686. 32 indexed citations
9.
Borràs, Ester, Kyle Chang, Mala Pande, et al.. (2017). In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prevention Research. 10(10). 580–587. 12 indexed citations
10.
Goldstein, Jennifer B., William Ka Kei Wu, Ester Borràs, et al.. (2017). Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?. Clinical Cancer Research. 23(17). 5246–5254. 30 indexed citations
11.
Sunga, Annette Y., Charité Ricker, Carin R. Espenschied, et al.. (2017). Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome. Cancer Genetics. 212-213. 1–7. 8 indexed citations
12.
DiNardo, Courtney D., Sarah A. Bannon, Mark J. Routbort, et al.. (2016). Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clinical Lymphoma Myeloma & Leukemia. 16(7). 417–428.e2. 66 indexed citations
13.
Mork, Maureen E., Ester Borràs, Melissa W. Taggart, et al.. (2016). Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency. Familial Cancer. 15(4). 587–591. 5 indexed citations
14.
Mork, Maureen E., Melissa W. Taggart, Miguel A. Rodrı́guez-Bigas, et al.. (2016). Identification of MSH2 inversion of exons 1–7 in clinical evaluation of families with suspected Lynch syndrome. Familial Cancer. 16(3). 357–361. 8 indexed citations
15.
Bannon, Sarah A. & Courtney D. DiNardo. (2016). Hereditary Predispositions to Myelodysplastic Syndrome. International Journal of Molecular Sciences. 17(6). 838–838. 43 indexed citations
16.
Dineen, Seán, Patrick M. Lynch, Miguel A. Rodrı́guez-Bigas, et al.. (2015). A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. Journal of the National Comprehensive Cancer Network. 13(7). 865–872. 10 indexed citations
17.
Vilar, Eduardo, Maureen E. Mork, Ester Borràs, et al.. (2014). Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genetics. 207(10-12). 495–502. 14 indexed citations
18.
Bannon, Sarah A., Maureen E. Mork, Eduardo Vilar, et al.. (2014). Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference. Hereditary Cancer in Clinical Practice. 12(1). 1–1. 19 indexed citations
19.
Rich, Thereasa A., Mei Liu, Carol J. Etzel, et al.. (2013). Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Familial Cancer. 13(2). 291–299. 57 indexed citations
20.
Pande, Mala, Chongjuan Wei, Jinyun Chen, et al.. (2012). Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Familial Cancer. 11(3). 441–447. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026